HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.

Abstract
Nine positron emission tomography studies of regional cerebral glucose metabolism were performed in 7 patients with probable striatonigral degeneration, a disorder characterized by parkinsonian features and absent or poor response to L-dopa. When compared with values obtained in normal volunteers, mean cerebral glucose metabolism was slightly reduced in subjects with striatonigral degeneration who, in addition, had a marked (20.5%, +/- 3 SD) relative hypometabolism in putaminal and caudate nuclei. Significant hypometabolism was also found in motor/premotor as well as in prefrontal cortex. In 2 subjects who were studied twice a deterioration of relative striatal metabolism paralleled clinical evolution. Magnetic resonance imaging disclosed the presence of abnormal iron deposits in the putamen in all cases but showed no cortical anomalies. These results suggest that positron emission tomography with [18F]fluorodeoxyglucose may provide an index of cell and processes degeneration in the striatum in striatonigral degeneration and is able to detect functional deficits in frontal cortex. The presence of striatal hypometabolism might be a predictor of a poor response to L-dopa.
AuthorsA G De Volder, J Francart, C Laterre, G Dooms, A Bol, C Michel, A M Goffinet
JournalAnnals of neurology (Ann Neurol) Vol. 26 Issue 2 Pg. 239-47 (Aug 1989) ISSN: 0364-5134 [Print] United States
PMID2789014 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorodeoxyglucose F18
  • Deoxyglucose
  • Glucose
Topics
  • Aged
  • Brain Diseases (diagnosis, diagnostic imaging, metabolism)
  • Corpus Striatum (diagnostic imaging, metabolism, pathology)
  • Deoxyglucose (analogs & derivatives)
  • Female
  • Fluorodeoxyglucose F18
  • Frontal Lobe (diagnostic imaging, metabolism, pathology)
  • Glucose (pharmacokinetics)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Substantia Nigra (pathology)
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: